-
1
-
-
14544291028
-
Extracellular transglutaminase: Factor XIII
-
Ichinose A. Extracellular transglutaminase: factor XIII. Prog Exp Tumor Res 2005; 38:192-208.
-
(2005)
Prog Exp Tumor Res
, vol.38
, pp. 192-208
-
-
Ichinose, A.1
-
2
-
-
79960076132
-
Factor XIII: A coagulation factor with multiple plasmatic and cellular functions
-
Muszbek L, Bereczky Z, Bagoly Z, Komá romi I, Katona E. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011; 91:931-972.
-
(2011)
Physiol Rev
, vol.91
, pp. 931-972
-
-
Muszbek, L.1
Bereczky, Z.2
Bagoly, Z.3
Komáromi, I.4
Katona, E.5
-
3
-
-
79955776731
-
As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan
-
Ichinose A, Souri M, Japanese collaborative research group on 'Acquired haemorrha-philia due to factor XIII deficiency'. As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan. Thromb Haemost 2011; 105:925-927.
-
(2011)
Thromb Haemost
, vol.105
, pp. 925-927
-
-
Ichinose, A.1
Souri, M.2
-
4
-
-
79961066578
-
Hemorrhagic acquired factor xiii (13) deficiency and acquired hemorrhaphilia 13 revisited
-
Ichinose A. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 2011; 37:382-388.
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 382-388
-
-
Ichinose, A.1
-
6
-
-
33847411624
-
Acquired hemophilia A in the United Kingdom: A 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' organisation
-
DOI 10.1182/blood-2006-06-029850
-
Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, for the UK Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007; 109:1870-1877. (Pubitemid 46348182)
-
(2007)
Blood
, vol.109
, Issue.5
, pp. 1870-1877
-
-
Collins, P.W.1
Hirsch, S.2
Baglin, T.P.3
Dolan, G.4
Hanley, J.5
Makris, M.6
Keeling, D.M.7
Liesner, R.8
Brown, S.A.9
Hay, C.R.M.10
-
7
-
-
84857632288
-
Reduced difference of a(2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to antifactor XIII antibodies
-
Ichinose A, Souri M. Reduced difference of a(2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to antifactor XIII antibodies. Int J Hematol 2012; 55:47-50.
-
(2012)
Int J Hematol
, vol.55
, pp. 47-50
-
-
Ichinose, A.1
Souri, M.2
-
8
-
-
41849131483
-
Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice
-
Souri M, Koseki-Kuno S, Takeda N, Degen JL, Ichinose A. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int J Hematol 2008; 87:60-68.
-
(2008)
Int J Hematol
, vol.87
, pp. 60-68
-
-
Souri, M.1
Koseki-Kuno, S.2
Takeda, N.3
Degen, J.L.4
Ichinose, A.5
-
9
-
-
79960143603
-
Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on drug-induced hemolytic anemia
-
Pierce A, Nester T, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol 2011; 136:7-12.
-
(2011)
Am J Clin Pathol
, vol.136
, pp. 7-12
-
-
Pierce, A.1
Nester, T.2
-
10
-
-
77955415920
-
Immune hemolytic anemia associated with drug therapy
-
Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010; 24:143-150.
-
(2010)
Blood Rev
, vol.24
, pp. 143-150
-
-
Garratty, G.1
-
11
-
-
22544464411
-
The changing spectrum of drug-induced immune hemolytic anemia
-
DOI 10.1053/j.seminhematol.2005.04.004, PII S0037196305000570
-
Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005; 42:137-144. (Pubitemid 41019442)
-
(2005)
Seminars in Hematology
, vol.42
, Issue.3
, pp. 137-144
-
-
Arndt, P.A.1
Garratty, G.2
-
12
-
-
0025872609
-
Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia
-
Krumdieck R, Shaw DR, Huang ST, Poon MC, Rustagi PK. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. Am J Med 1991; 90:639-645.
-
(1991)
Am J Med
, vol.90
, pp. 639-645
-
-
Krumdieck, R.1
Shaw, D.R.2
Huang, S.T.3
Poon, M.C.4
Rustagi, P.K.5
-
13
-
-
18844402183
-
Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin
-
Miesbach W. Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin. Thromb Haemost 2005; 93:1001-1003. (Pubitemid 40691564)
-
(2005)
Thrombosis and Haemostasis
, vol.93
, Issue.5
, pp. 1001-1003
-
-
Miesbach, W.1
Boehm, M.2
Scharrer, I.3
-
14
-
-
84862854584
-
Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control
-
Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol 2012; 95:362-370.
-
(2012)
Int J Hematol
, vol.95
, pp. 362-370
-
-
Ichinose, A.1
-
15
-
-
18844381129
-
Acquired factor XIII deficiency due to an inhibitor: A case report and review of the literature
-
Nijenhuis AV, van Bergeijk L, Huijgens PC, Zweegman S. Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature. Haematologica 2004; 89:e46-e48.
-
(2004)
Haematologica
, vol.89
-
-
Nijenhuis, A.V.1
Van Bergeijk, L.2
Huijgens, P.C.3
Zweegman, S.4
|